Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2007
11/01/2007US20070255301 Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
11/01/2007US20070255249 System for growth, analysis, storage, validation and distribution of cells and tissues used for biomedical purposes
11/01/2007US20070255123 Analyte testing device
11/01/2007US20070255045 O-acetyl-ADP ribose, a histone deacetylase-reaction product, used for producing polyclonal or monoclonal antibodies, and for analysis by competitive binding assaying of aging resistance and/or anticarcinogenic agents
11/01/2007US20070255043 MN gene and protein
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254903 Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254831 PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn
11/01/2007US20070254830 Interaction of Colon Cancer Related Gene C200RF20 With P120
11/01/2007US20070254382 Method and biosensor for analysis
11/01/2007US20070254381 Monitoring and/or treating syringe mechanism
11/01/2007US20070254379 polydimethylsiloxane upper plates; fluoresence; polymerase chain reactions
11/01/2007US20070254374 Water quality analyzer
11/01/2007US20070254373 Fragments of fluorescent proteins for protein fragment complementation assays
11/01/2007US20070254372 Method and device for the detection of molecular interactions
11/01/2007US20070254371 Peptide combos and their uses
11/01/2007US20070254370 Method and kit for detecting the early onset of renal tubular cell injury
11/01/2007US20070254369 Methods and apparatus for identifying disease status using biomarkers
11/01/2007US20070254360 Expression vector comprising nucleotide sequences coding dorsal-ventral patterning fusion protein for use as tool in enhancement of immune response in infected cells
11/01/2007US20070254330 Use of Isogenic Drug-Resistant Cell Lines to Determine the Sequence of Chemotherapeutic Drug Treatment
11/01/2007US20070254326 Method for Detecting Streptococcus Agalactiae Using Esterase Activity
11/01/2007US20070254323 Malachite green derivatives for immunoassay reagents to detect malachite green
11/01/2007US20070254322 Complement-based analyte assay
11/01/2007US20070254321 Lytic Enzymes and Spore Surface Antigen for Detection and Treatment of Bacillus Anthracis Bacteria and Spores
11/01/2007US20070254320 Method and Kit for Detecting Listeria Spp.
11/01/2007US20070254319 Identification of a constitutively resistant cancer stem cell
11/01/2007US20070254318 Inhibition of cell proliferation
11/01/2007US20070254317 Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate
11/01/2007US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007US20070254315 Screening for neurotoxic amino acid associated with neurological disorders
11/01/2007US20070254314 Methods of treating autism and autism spectrum disorders
11/01/2007US20070254313 Gnal Splice Variant and Uses Thereof
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
11/01/2007US20070254311 Covalent modification and conjugation of luciferase
11/01/2007US20070254310 Compositions and assays utilizing ADP or phosphate for detecting protein modulators
11/01/2007US20070254309 Methods for Assessing Embryo Viability
11/01/2007US20070254308 Amplified array analysis method and system
11/01/2007US20070254307 Method for Estimation of Location of Active Sites of Biopolymers Based on Virtual Library Screening
11/01/2007US20070254303 Methods for assessing the efficacy of treatment with a glucocorticoid
11/01/2007US20070254300 Compositions and methods for treating inflammatory disorders
11/01/2007US20070254295 Methods of predicting and monitoring tyrosine kinase inhibitor therapy
11/01/2007US20070254289 Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
11/01/2007US20070254287 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)
11/01/2007US20070254286 Molecular Markers that predict breast cancer development
11/01/2007US20070254285 Stable water-soluble polyethylenimine conjugates and methods of use thereof
11/01/2007US20070254283 Brhf1 as a Cancer Diagnostic Marker
11/01/2007US20070254281 Specific Marker Lmx1a on Dopaminergic Neurons
11/01/2007US20070253970 Enzymatic polypeptide sequences which target and destroy cancer cells
11/01/2007US20070253968 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
11/01/2007US20070253965 Reagents for Diagnosis and Therapy of Latex Allergy and Method for the Preparation of the Same
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253949 Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
11/01/2007US20070253948 Anti-FC-gamma RIIB receptor antibody and uses therefor
11/01/2007US20070253946 Axon Regeneration Promoter
11/01/2007US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007US20070253907 Non Human Transgenic Animal as Model of Neurodegenerative Diseases and for the Early Diagnosis Thereof
11/01/2007US20070253906 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
11/01/2007US20070253905 Abeta42 LOWERING AGENTS
11/01/2007US20070253904 administering a diabetic patient a formulation containing an aryl hydrocarbon receptor nuclea rtranslocator (ARNT) polypeptide to treat diabetes type I, diabetes type II, impaired glucose tolerance, insulin resistance, and beta cell dysfunction
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007US20070253871 Solid-state light source photolytic nitrogen dioxide converter
11/01/2007US20070252987 Method and apparatus for detecting biomolecular interactions
11/01/2007US20070252136 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors and fabricating such devices
11/01/2007US20070251885 Using microparticles comprising magnet elements as tools in isolation of biopolymers from solution
11/01/2007US20070251871 Integrated high throughput system for the analysis of biomolecules
11/01/2007US20070251836 Electrochemical sensor and method for analyzing liquid sample
11/01/2007US20070251337 Fluorescent detector systems for the detection of chemical perturbations in sterile storage devices
11/01/2007US20070251323 High throughput microbalance
11/01/2007US20070251311 Method and Device for the Contactless Detection of Flat Objects
11/01/2007US20070251300 Device for Controlling and Regulating the Physical-Biochemical Condition of a Liquid Mixture
11/01/2007CA2650699A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007CA2650008A1 Functionalization of metal nanoparticles with oriented proteins.
11/01/2007CA2649773A1 Assay
11/01/2007CA2649583A1 Methods and kits for early stage caries detection
11/01/2007CA2649580A1 Method and measuring device for measuring recycled fibre pulp
11/01/2007CA2649535A1 Thermostable proteins and methods of making and using thereof
11/01/2007CA2649359A1 Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides through three-dimensional interactions
11/01/2007CA2649037A1 Anti-factor xiia therapy
11/01/2007CA2648850A1 Method for assaying antigens
11/01/2007CA2648578A1 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
11/01/2007CA2648106A1 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
11/01/2007CA2648096A1 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/01/2007CA2647671A1 Treatment of tumors expressing mutant egf receptors
11/01/2007CA2647383A1 Detection of membrane androgen receptor (mar) agents
11/01/2007CA2647099A1 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
11/01/2007CA2646526A1 Methods and compositions for expressing negative-sense viral rna in canine cells
11/01/2007CA2646309A1 Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
11/01/2007CA2645853A1 Methods of determining cellular chemosensitivity
11/01/2007CA2639070A1 Novel tumour suppressor
11/01/2007CA2633715A1 Translational dysfunction based therapeutics
10/2007
10/31/2007EP1850135A1 Method for determining the thrombocyte function and flow conditions
10/31/2007EP1850134A1 Method and Apparatus for the determination of the Thromboyte function and flow conditions
10/31/2007EP1850133A1 Method for determining high ristocetin cofactor activity of the von Willebrand factor
10/31/2007EP1850132A1 Method for determining the ratio of two distinct peptides or polynucleic acids
10/31/2007EP1850131A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
10/31/2007EP1850130A1 Gene markers and utilzation of the same
10/31/2007EP1850119A1 Optical sensor and method for optical inspection of surfaces